Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Can Trulicity® (dulaglutide) be used while a patient is breastfeeding?

Eli Lilly and Company has no data for the use of dulaglutide in patients that are breastfeeding.


See important safety information, including boxed warning, in the attached prescribing information.

Use During Lactation

There are no data on

  • the presence of dulaglutide in human milk
  • the effects on the breastfed infant, or
  • the effects on milk production.1

The presence of dulaglutide in milk of treated lactating animals was not determined.1

The developmental and health benefits of breastfeeding should be considered along with

  • the mother’s clinical need for dulaglutide, and
  • any potential adverse events on the breastfed infant from dulaglutide or from the underlying maternal condition.1


1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: April 11, 2022

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical